Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CATX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 236.88M
March 31, 2026 270.93M
December 31, 2025 144.74M
September 30, 2025 174.14M
June 30, 2025 191.58M
March 31, 2025 211.70M
December 31, 2024 226.92M
September 30, 2024 267.85M
June 30, 2024 292.87M
March 31, 2024 180.65M
December 31, 2023
September 30, 2023 17.98M
June 30, 2023 28.32M
March 31, 2023 36.45M
June 30, 2022 55.89M
March 31, 2022 58.90M
December 31, 2021 60.35M
September 30, 2021 61.69M
June 30, 2021 63.83M
March 31, 2021 64.84M
December 31, 2020 9.585M
September 30, 2020 1.94M
June 30, 2020 2.392M
March 31, 2020 2.405M
December 31, 2019 3.18M
Date Value
September 30, 2019 4.575M
June 30, 2019 5.326M
March 31, 2019 6.392M
December 31, 2018 7.868M
September 30, 2018 9.193M
June 30, 2018 3.425M
March 31, 2018 4.515M
December 31, 2017 5.676M
September 30, 2017 7.256M
June 30, 2017 8.971M
March 31, 2017 10.41M
December 31, 2016 11.95M
September 30, 2016 13.71M
June 30, 2016 12.39M
March 31, 2016 11.61M
December 31, 2015 12.60M
September 30, 2015 13.48M
June 30, 2015 14.59M
March 31, 2015 10.16M
December 31, 2014 11.38M
September 30, 2014 12.10M
June 30, 2014 17.68M
March 31, 2014 23.70M
December 31, 2013 4.415M
September 30, 2013 5.284M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. 38.41M
MiMedx Group, Inc. 135.84M
ABVC BioPharma, Inc. 0.0944M
Enovis Corp. 12.56M
Edwards Lifesciences Corp. 4.255B